ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Lam Research Corp

Lam Research Corp (1LRCX)

82.39
-3.31
( -3.86% )
Updated: 06:38:17

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
82.39
Bid
83.06
Ask
83.34
Volume
167
73.95 Day's Range 82.39
66.33 52 Week Range 1,059.20
Market Cap
Previous Close
85.70
Open
81.90
Last Trade
57
@
82.39
Last Trade Time
04:10:04
Financial Volume
-
VWAP
-
Average Volume (3m)
119
Shares Outstanding
1,283,662,000
Dividend Yield
1.17%
PE Ratio
28.85
Earnings Per Share (EPS)
2.98
Revenue
14.91B
Net Profit
3.83B

About Lam Research Corp

Sector
Special Industry Machy, Nec
Industry
Special Industry Machy, Nec
Headquarters
Wilmington, Delaware, USA
Founded
-
Lam Research Corp is listed in the Special Industry Machy sector of the Italian Stock Exchange with ticker 1LRCX. The last closing price for Lam Research was 85.70 €. Over the last year, Lam Research shares have traded in a share price range of 66.33 € to 1,059.20 €.

Lam Research currently has 1,283,662,000 shares outstanding. The market capitalization of Lam Research is 110.01 € billion. Lam Research has a price to earnings ratio (PE ratio) of 28.85.

1LRCX Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.561.9299764938880.8386.1573.9524183.68828482DE
49.3912.86301369867386.1571.2611980.37632105DE
1211.8616.815539486770.5386.1566.8611975.39736067DE
26-643.91-88.6562026711726.3764.566.339384.1522193DE
52-781.61-90.46412037048641059.266.3359153.40089882DE
156-625.51-88.3613504732707.91059.266.3352173.7462705DE
260-625.51-88.3613504732707.91059.266.3352173.7462705DE

1LRCX - Frequently Asked Questions (FAQ)

What is the current Lam Research share price?
The current share price of Lam Research is 82.39 €
How many Lam Research shares are in issue?
Lam Research has 1,283,662,000 shares in issue
What is the market cap of Lam Research?
The market capitalisation of Lam Research is EUR 110.01B
What is the 1 year trading range for Lam Research share price?
Lam Research has traded in the range of 66.33 € to 1,059.20 € during the past year
What is the PE ratio of Lam Research?
The price to earnings ratio of Lam Research is 28.85
What is the cash to sales ratio of Lam Research?
The cash to sales ratio of Lam Research is 7.41
What is the reporting currency for Lam Research?
Lam Research reports financial results in USD
What is the latest annual turnover for Lam Research?
The latest annual turnover of Lam Research is USD 14.91B
What is the latest annual profit for Lam Research?
The latest annual profit of Lam Research is USD 3.83B
What is the registered address of Lam Research?
The registered address for Lam Research is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Lam Research website address?
The website address for Lam Research is www.lamresearch.com
Which industry sector does Lam Research operate in?
Lam Research operates in the SPECIAL INDUSTRY MACHY, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WPAL26Palingeo SpA
0.236 €
(21.15%)
6
NTWNetweek SpA
0.0588 €
(20.00%)
1.54M
WS3D25Solid World Group spa
0.1099 €
(15.68%)
4k
ZESTZest SpA
0.1715 €
(9.24%)
1.5M
AURNB Aurora SA SicafRaif
10.30 €
(8.42%)
529.75k
1NKLANikola Corp
0.272 €
(-33.66%)
45.02k
WART28DeodatoGallery SpA
0.04 €
(-29.82%)
2.45k
1VARVarta AG
1.411 €
(-25.74%)
53.1k
MTVFRMondo TV France
0.009 €
(-23.73%)
130k
1SPCEVirgin Galactic Holdings Inc
4.00 €
(-20.00%)
206
SPMSaipem Spa
2.308 €
(-0.60%)
107.29M
TITTelecom Italia SpA
0.2737 €
(0.92%)
93.66M
ISPIntesa Sanpaolo Spa
4.5345 €
(0.31%)
20.28M
BMPSBanca Monte Dei Paschi Di Siena Spa
6.642 €
(3.30%)
12.86M
ENELEnel Spa
6.942 €
(1.39%)
11.57M

Discussion

View Full Feed
manibiotech manibiotech 1 minute ago
Agree 
At the end of the day it's the court's opinion that counts and matters . Hopefully Wood may do something more favorable .
But eventually whatever court rules is the bottom line . One can write their personal opinions here all they want , it is meaningless and inconsequential . 
NWBO
ksquared ksquared 1 minute ago
Covergirl...
What a beast.
https://nypost.com/wp-content/uploads/sites/2/2025/02/FEBRUARY24.P1_LCF.jpg?resize=400,441&quality=90&strip=all&w=750
Investor082 Investor082 2 minutes ago
Nope. No hiring & No reimbursement tells you all you need to know. They will be diluting endlessly in penny land. No big pharma will provide non dilutive funds. Forget about major institutional investors. This management has done nothing but lost money of investors for 10-12 years. No one is going t
NWBO
glenn1919 glenn1919 2 minutes ago
ORIS................................https://stockcharts.com/h-sc/ui?s=ORIS&p=W&b=5&g=0&id=p86431144783#google_vignette
ORIS
Monksdream Monksdream 3 minutes ago
Top 15 at 6:50
Same Asian tickers from Friday night


https://ih.advfn.com/markets/nasdaq/premarket
Monksdream Monksdream 3 minutes ago
Top 15 at 6:50
Same Asian tickers from Friday night


https://ih.advfn.com/markets/nasdaq/premarket
FeMike FeMike 3 minutes ago
What a huge wall of utterly worthless garbage.

This isn’t happening. Just stop.
NWBO
glenn1919 glenn1919 5 minutes ago
reto...............................https://stockcharts.com/h-sc/ui?s=RETO&p=W&b=5&g=0&id=p86431144783#google_vignette
RETO
PutzMueler PutzMueler 6 minutes ago
Dan’s chart

thanks Daniel D.


A lot to digest
https://stockcharts.com/sc3/ui/?s=NB

Flag, Golden Cross, long legged Doji, below 20 DMA but above $2.20 support.

Should see market sentiment
News would be nice soon.
NB
Jake731 Jake731 6 minutes ago
Good morning all. 





TPTW……!!!!!!!
TPTW
glenn1919 glenn1919 7 minutes ago
STEC..............................weeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
STEC
RealDutch RealDutch 9 minutes ago
I don't expect them to deliver today. The probability is close to 0.1%
ITUP
dennisdave dennisdave 10 minutes ago
Does Advent do any work for NWBO that requires compensation? No idea but certainly of such magnitude that it accounts for ALL of Advents costs including the 84 staff.

There is a high cost to provide compassionate care batches for patients, to do process improvement activities such a
NWBO
dmb2 dmb2 14 minutes ago
Your interpretation is a baseless allegation. Toucan owns Advent but NW owns the facility, good thing most real investors here know the difference between informed and baseless posters such as yourself.

The significant time it has taken has also been discussed at length. This underta
NWBO
Investor2014 Investor2014 15 minutes ago
Bot template nonsense!
AVXL
Real McCoy Real McCoy 16 minutes ago
You’re out 100% and were proven wrong.

That’s it.
work-n-hard work-n-hard 16 minutes ago
NIXX: Checked this one out last night and have it on watch. ✅️
NIXX
dennisdave dennisdave 17 minutes ago
I understand, and I'm sure the magistrate is doing his best to remain fair and impartial. Despite that, however, so you put more value on Posner's arguments than the magistrate's findings. If you value your own opinion over that of a judge then you demonstrate being incapable of really observing imp
NWBO
valuemind valuemind 17 minutes ago
I sold META (FB at that time) at about $35 at the first time, and then at about 150, for the nice profit. I felt very smart to predict its revenue and earning growth at the time. In the end, I not only missed the fast boat, but also paid tax on realized capital gain. As a result, I accept I am not g
docj docj 19 minutes ago
MGK_2

9h ago
"Hope Rugo’s TNBC Nuke (UCSF): She ran leronlimab with carboplatin in 2019—stable disease at ASCO 2020. January 15 news says her 2025 TNBC basket trial’s live. Her bio whispers “CCR5 research”—leronlimab in there? It’s a sleeper atom bomb. Rugo’s a cancer titan; t
CYDY
docj docj 19 minutes ago
MGK_2

9h ago
"Hütter’s Legacy Reload (Germany): Gero Hütter’s Berlin Patient cure—CCR5-delta 32 king, SAB relic. His 2008 win powers LATCH—a murmur from him flips HIV upside down."

"In September 2020, CytoDyn had this press release: https://www.globenewswire.com
CYDY
docj docj 20 minutes ago
MGK_2

9h ago
"Montefiore’s Neuro Bet: Beyond oncology, the Einstein/Montefiore preclinicals (March 2024) and Cornell’s Alzheimer’s pilot (December 2024) hint at CCR5’s brain inflammation role. A neurodegeneration win’s a $50B market—CYDY’s dark pool."

"27:15 Nad
CYDY
sctts sctts 21 minutes ago
$$$ Today is the Day $$$$

$$$$ $FRX $$$
FRX
misterfishman misterfishman 21 minutes ago
Soon I hope.
RDAR
misterfishman misterfishman 22 minutes ago
True that my big bro. I think peeps are holding this expecting big new soon .this is after all a way under valued 100 mill and counting RM in the making when its all said and done this could be a billion dollar stock we buy for subpennies now that is nuts if all of it is true.
IGPK

Your Recent History

Delayed Upgrade Clock